ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,732Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 12

$789K Total Retail Price of All Prescriptions

Rank: 2 out of 12

732 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 732 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

11% of this provider’s 732 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 10,840 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 650 615 1 1
LISINOPRIL 551 538 2 2
SIMVASTATIN 502 453 3 3
AMLODIPINE BESYLATE 366 363 4 5
HYDROCHLOROTHIAZIDE 336 330 5 10
HYDROCODONE-ACETAMINOPHEN 317 280 S3 6 9
OMEPRAZOLE 271 263 7 4
ZOLPIDEM TARTRATE 229 227 8 21
ALENDRONATE SODIUM 199 187 9 20
LOSARTAN POTASSIUM 186 179 10 26
ATORVASTATIN CALCIUM 164 164 11 27
FUROSEMIDE 160 156 12 6
ATENOLOL 148 143 13 22
METOPROLOL SUCCINATE 146 144 14 24
METOPROLOL TARTRATE 145 137 15 7
SERTRALINE HCL 143 134 16 19
METFORMIN HCL 138 133 17 14
GABAPENTIN 134 108 18 17
DIOVAN 128 128 19 38
METFORMIN HCL ER 123 108 20 67
NAMENDA 120 116 21 13
ADVAIR DISKUS 119 103 22 32
PRAVASTATIN SODIUM 111 89 23 46
DONEPEZIL HCL 107 107 24 11
FLUOXETINE HCL 107 94 24 74
FLUTICASONE PROPIONATE 106 99 26 35
NEXIUM 105 92 27 75
CITALOPRAM HBR 94 88 28 16
SYNTHROID 92 92 29 52
VENLAFAXINE HCL ER 91 78 30 84
PANTOPRAZOLE SODIUM 90 79 31 37
ALLOPURINOL 89 82 32 51
SPIRIVA 89 87 32 43
CYMBALTA 87 75 34 54
CRESTOR 86 78 35 59
TAMSULOSIN HCL 85 82 36 23
TRAZODONE HCL 84 84 37 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 77 37 62
LOVASTATIN 82 78 39 30
PROAIR HFA 80 69 40 63
EXELON 78 78 41 33
TRIAMTERENE-HCTZ 77 75 42 60
PAROXETINE HCL 76 72 43 39
PROPRANOLOL HCL 76 65 43 88
SPIRONOLACTONE 75 69 45 50
AZITHROMYCIN 74 71 46 66
ESCITALOPRAM OXALATE 73 69 47 33
TRAMADOL HCL 70 68 48 18
MIRTAZAPINE 66 66 49 15
CELEBREX 63 49 50 68
ZETIA 62 61 51 72
CLOPIDOGREL 59 59 52 36
CIPROFLOXACIN HCL 59 56 52 49
DIVALPROEX SODIUM 56 56 54 29
PREDNISONE 55 52 55 58
JANUVIA 55 39 55 41
WARFARIN SODIUM 54 41 57 12
LEVOXYL 53 53 58 106
FINASTERIDE 51 41 59 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 21, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.